Five papers
by Jessica K Hartman
- MB Black, A Stern, P Mallick, M Moreau, JK Hartman, PD McMullen, and AY Efremenko. Biological system considerations for application of toxicogenomics in next-generation risk assessment and predictive toxicology. Toxicol In Vitro 80 : 105311 (Apr 14, 2022). [abstract] [pubmed]
- A Mistry, LE Bowen, MW Dzierlenga, JK Hartman, and SD Slattery. Development of an in vitro approach to point-of-contact inhalation toxicity testing of volatile compounds, using organotypic culture and air-liquid interface exposure. Toxicol In Vitro 69 : 104968 (Dec 15, 2020). [abstract] [pubmed]
- T Beames, M Moreau, LA Roberts, K Mansouri, S Haider, M Smeltz, CI Nicolas, D Doheny, MB Phillips, M Yoon, RA Becker, PD McMullen, ME Andersen, RA Clewell, and JK Hartman. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay. Toxicol Appl Pharmacol 387 : 114774 (Jan 15, 2020). [abstract] [pubmed]
- ME Andersen, PD McMullen, MB Phillips, M Yoon, SN Pendse, HJ Clewell, JK Hartman, M Moreau, RA Becker, and RA Clewell. Developing context appropriate toxicity testing approaches using new alternative methods (NAMs). ALTEX 36 (4) : 523-534 (Jan 1, 2019). [abstract] [pubmed]
- JK Hartman, T Beames, B Parks, D Doheny, G Song, M Yoon, B Foley, C Deisenroth, PD McMullen, RA Clewell, and AY Efremenko. An in vitro approach for prioritization and evaluation of chemical effects on glucocorticoid receptor mediated adipogenesis. Toxicol Appl Pharmacol 355 : 112-126 (Sep 15, 2018). [abstract] [pubmed]